Latest Bacteriophages Stories
Dyax Corp. (NASDAQ: DYAX) and AVEO Pharmaceuticals, Inc. announced today that Dyax has granted AVEO a non-exclusive license to Dyax's proprietary antibody phage display libraries for the discovery and development of therapeutic antibodies. Dyax's human antibody phage libraries combine gene fragments from human donors with strategically designed synthetic DNA, and are used to identify high-affinity human antibodies that bind to numerous therapeutic targets, including cell surface proteins such...
The human antibody company, Affitech AS, announced today that it has further strengthened its intellectual property (IP) position in the human antibody discovery area through a series of IP cross-licensing and in-licensing deals. The Company's primary antibody library display patents are known as "Breitling" IP. Originating from the DKFZ (German Cancer Research Center) of Heidelberg, Germany, the Breitling patents cover the use of full-length pIII phage protein as a scaffold in a...
Latest Bacteriophages Reference Libraries
Klebsiella pneumoniae is a Gram-negative, non-motile, encapsulated, lactose fermenting, facultative anaerobic, rod shaped bacterium found in the normal flora of the mouth, skin, and intestines. It is the most important member of the Klebsiella genus of Enterobacteriaceae. It is naturally occurring in soil and about 30% of strains can fix nitrogen in anaerobic conditions. Hans Christian Gram developed the technique now known as Gram staining in 1884 to discriminate between K. pneumoniae and...
